OCTOBER 12, 2018 – FRIDAY
Time Hall A Hall B Hall C
09:00 – 10:30 S11. A harmonised approach to generating and applying biological variation data

 

 

Chairs:

Elvar Theodorsson & TBA

S12. Role of Gut microbiota in metabolism and inflammatory bowel diseases

 

 

Chairs:

Stelios Chatzipanagiotou & Nurdan Tozun

Biological variation, from theory to practice. The projects of EFLM
Sverre Sandberg
Gut microbiota and its relationship with obesity, metabolic syndrome and diabetes
Ahmet Uygun
European Biological Variation Study (EuBIVAS): Sample collections from healthy volunteers from six European Labs for biological variation estimates’ update
Anna Carobene 
Celiac disease antibody testing: New trends in diagnosis, guidelines and new markers
Jurgen Stein  
Biological variation of CBC tests: The effect of turnarover time
Abdurrahman Coskun
Faecal biomarkers in diagnosis and monitoring of inflammatory bowel disease
Murat Toruner
10:30 – 10:45 Coffee Break & Posters
10:45 – 11:30 Plenary Lecture: The Liver: Maestro of metabolism

 

 

Chair: Howard Morris

Speaker: Nurdan Tozun

11:30 – 12:10 Industry-Sponsored Symposium 

 

 

Abbott

INNOVATIVE SOLUTIONS TO ACHIEVE MEASURABLY BETTER
HEALTHCARE PERFORMANCE IN THE CORE LAB

Chair: Ozkan Alatas

Alinity and the next generation core lab: Data behind measurably better healthcare performance
Nilufer Bayraktar

Improving lab productivity with existing resources: Test pattern optimization through the power of AlinIQ
Ataman Gonel

 

12:10 – 13:00 Lunch & Posters
13:00 – 14:30 IATDMCT Symposium

 

 

Chairs:

Maria Shipkova & Eberhard Wieland

S17. Harmonisation of training and continuing professional development in laboratory medicine

 

 

Chairs:

Augusto Machado & Fatma Taneli

Oral Presentations

Chairs:

Evin Ademoğlu & Ece Onur

13:00-13:10 Does Table Salt Help Pass A Drug Test In Urine?
Soycan Mizrak
13:10-13:20 1,25-Dihydroxyvitamin D3 Attenuates Matrix Metalloproteinase Expression By İnhibition Of İnflammatory Process İn Chondrosarcoma Cells
Gamze Avcioglu
13:20-13:30 Effect Of Ozone On Colon Anastomoses In A Rat Peritonitis Model
Feyza Yagmur Tekeli
13:30-13:40 Translating Mass Spectrometry-Based Protein Assays And The Challenging Road Ahead: Post-Translationally Modified Proteins As Biomarker Targets For Clinical MS Protein Tests
Dobrin Nedelkov
13:40-13:50 SHFI: A Novel Noninvasive Predictive Model for Significant Fibrosis in Patients With Chronic Hepatitis B
Banu Isbilen Basok
13:50-14:00 Simultaneous Determination of Fat Soluble Vitamins by Liquid Chromatography Tandem Mass Spectrometry
Sebla Ertugrul
14:00-14:10 Serum Secreted Phospholipase A2 Levels In Cardiac Damage Determined Scintigraphically
Hale Aral
14:10-14:20 MicroRNAs as biomakers associated with overactive bladder
Elif Firat
14:20-14:30 Hematological changes in patients with diabetes type 2 treated with metformin
Marsida Janko

 

The future of LC-MS/MS in forensic laboratory and clinical toxicology
Katharina Rentsch
Curricula of laboratory medicine in medical schools
Thomas Zima
Therapeutic drug monitoring in transplant patients
Eberhard Wieland
Standardization of education of specialists on medical biochemistry in Turkey
Pinar Tuncel
Therapeutic drug monitoring for anti-hypertensive drugs
Erik van Maarseveen
Education of specialists on laboratory medicine in EU
Matthias Orth
14:30 – 14:45 Coffee Break & Posters
14:45 – 15:25 Industry Sponsored Symposium

 

Snibe

 

The Fully Automatic CLIA Solution for Free Testosterone Testing: How Does Laboratory Innovation help Clinical Diagnostic

 

Humeyra Ozturk Emre

 

Biochemistry Specialist, Ministry of Health, Istanbul Education and Research Hospital


15:25 – 16:25 S18. Strategic role of laboratory management and leadership in clinical outcome

 

 

Chairs:

Tamer Inal & Pinar Tuncel

S1. The role of clinical laboratories in diagnosis and manegement of cancer

 

 

Chairs:

Meltem Kilercik & TBA

 

 

 

 

 

The role of laboratory specialist in clinical diagnostic team
Roberto Verna
Therapy-resistant non-small cell lung carcinoma –  The role of molecular tumor boards for clinical management

 

Leon van Kempen

Laboratory medicine in the new regulatory and healthcare environment: From essentialism to consequentialism
Fatma Taneli
The impact of flow cytometry in clinical laboratory
Brent L. Wood
16:25 – 16:40 Coffee Break
16:40 – 17:40 S13. Autoimmunity, allergic disorders and immunodeficiency

 

 

Chairs:

Burcu Barutcuoglu & Jurgen Stein

S9. Personalized medicine

 

 

Chairs:

Ian Watson & TBA

The role of the laboratory in diagnosis and management of autoimmune disease
Joanna Sheldon
The role of laboratory medicine in personalized and precision medicine
Mario Pazzagli 
The role of the laboratory in the diagnosis and management of allergic disease
Ravishankar Sargur
Personalized reference intervals
Yesim Ozarda
17:40 –  18:10 The role of the immunology laboratory in the diagnosis and management of primary immune deficiency
Kimberly Gilmour

*may subject to change